Citadel Advisors’s Zymergen Inc. Common Stock ZY Stock Holding History

Citadel Advisors’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,100	Closed	-$70K	–	16031
2022 Q3	$70K	Sell	25,100 -5,500	-18%	-$13.4K	﹤0.01%	11395
2022 Q2	$38K	Sell	30,600 -12,700	-29%	-$21.3K	﹤0.01%	12111
2022 Q1	$125K	Sell	43,300 -36,500	-46%	-$155K	﹤0.01%	12054
2021 Q4	$534K	Sell	79,800 -32,500	-29%	-$316K	﹤0.01%	9545
2021 Q3	$1.48M	Buy	112,300 +83,900	+295%	+$1.78M	﹤0.01%	7112
2021 Q2	$1.14M	Buy	+28,400	New	+$1.12M	﹤0.01%	8034

Citadel Advisors's ZY Position: Q4 2022 in Review

Citadel Advisors sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 23,345 shares — an estimated $65K sold.

Citadel Advisors first reported a position in ZY in Q2 2021 and held it in 5 quarters. The position peaked at $2.67M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Citadel Advisors reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 23,345 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $65K.
Citadel Advisors first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Citadel Advisors's Zymergen Inc. Common Stock position peaked at $2.67M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.